©The Author(s) 2025.
World J Cardiol. Oct 26, 2025; 17(10): 111941
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.111941
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.111941
Figure 2 Forest plots of pooled risk ratios for clinical outcomes comparing dual antiplatelet therapy vs single antiplatelet therapy in patients with peripheral artery disease undergoing lower extremity revascularization.
A: All-cause mortality; B: Cardiac mortality; C: Myocardial infarction; D: Stroke; E: Major reintervention; F: Bleeding.
- Citation: Shahid MM, Mandal D, Das A, Kumar P, Kumar N, Mukhtar A, Ejaz H, Jaffar MS, Habib M, Afzal A, Khawar MMH, Rana I. Dual versus single antiplatelet therapy after lower extremity revascularization in peripheral artery disease: A systematic review and meta-analysis. World J Cardiol 2025; 17(10): 111941
- URL: https://www.wjgnet.com/1949-8462/full/v17/i10/111941.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i10.111941